References: Ventilator-associated pneumonia

  • Abdul-Aziz MH, Hammond NE, Brett SJ, Cotta MO, De Waele JJ, Devaux A, et al. Prolonged vs Intermittent Infusions of beta-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis. JAMA 2024;332(8):638-48. https://pubmed.ncbi.nlm.nih.gov/38864162/
  • Aberegg SK, Wolfe BM. Aspergillosis in the ICU: Hidden Enemy or Bogeyman? Am J Respir Crit Care Med 2021;203(8):1043-4. https://www.ncbi.nlm.nih.gov/pubmed/33497586
  • American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171(4):388-416. https://www.ncbi.nlm.nih.gov/pubmed/15699079
  • Beye F, Vigneron C, Dargent A, Prin S, Andreu P, Large A, et al. Adhering to the procalcitonin algorithm allows antibiotic therapy to be shortened in patients with ventilator-associated pneumonia. J Crit Care 2019;53:125-31. https://www.ncbi.nlm.nih.gov/pubmed/31228763
  • Borman AM, Johnson EM. Name Changes for Fungi of Medical Importance, 2018 to 2019. J Clin Microbiol 2021;59(2). https://www.ncbi.nlm.nih.gov/pubmed/33028600
  • Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010;375(9713):463-74. https://www.ncbi.nlm.nih.gov/pubmed/20097417
  • Bougle A, Tuffet S, Federici L, Leone M, Monsel A, Dessalle T, et al. Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial. Intensive Care Med 2022;48(7):841-9. https://www.ncbi.nlm.nih.gov/pubmed/35552788
  • Boyd S, Sheng Loh K, Lynch J, Alrashed D, Muzzammil S, Marsh H, et al. Elevated Rates of Ventilator-Associated Pneumonia and COVID-19 Associated Pulmonary Aspergillosis in Critically Ill Patients with SARS-CoV2 Infection in the Second Wave: A Retrospective Chart Review. Antibiotics (Basel) 2022;11(5). https://www.ncbi.nlm.nih.gov/pubmed/35625276
  • Chen F, Qasir D, Morris AC. Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias. Semin Respir Crit Care Med 2022;43(2):234-42. https://www.ncbi.nlm.nih.gov/pubmed/35042260
  • Dulhunty JM, Brett SJ, De Waele JJ, Rajbhandari D, Billot L, Cotta MO, et al. Continuous vs Intermittent beta-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial. JAMA 2024;332(8):629-37. https://pubmed.ncbi.nlm.nih.gov/38864155/
  • Ehrenzeller S, Klompas M. Association Between Daily Toothbrushing and Hospital-Acquired Pneumonia: A Systematic Review and Meta-Analysis. JAMA Intern Med 2023. https://www.ncbi.nlm.nih.gov/pubmed/38109100
  • Fumagalli. Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients. Curr Opin Crit Care 2022;28(1):74-82. https://oce.ovid.com/article/00075198-202202000-00009/HTML
  • Hamade B, Huang DT. Procalcitonin: Where Are We Now? Crit Care Clin 2020;36(1):23-40. https://www.ncbi.nlm.nih.gov/pubmed/31733680
  • Hellyer TP, Ewan V, Wilson P, Simpson AJ. The Intensive Care Society recommended bundle of interventions for the prevention of ventilator-associated pneumonia. J Intensive Care Soc 2016;17(3):238-43. https://www.ncbi.nlm.nih.gov/pubmed/28979497
  • Iankova I, Thompson-Leduc P, Kirson NY, Rice B, Hey J, Krause A, et al. Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis. Crit Care Med 2018;46(5):691-8. https://www.ncbi.nlm.nih.gov/pubmed/29271844
  • Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016;63(5):e61-e111. https://www.ncbi.nlm.nih.gov/pubmed/27418577
  • Katz SE, Crook J, Gillon J, Stanford JE, Wang L, Colby JM, et al. Use of a Procalcitonin-guided Antibiotic Treatment Algorithm in the Pediatric Intensive Care Unit. Pediatr Infect Dis J 2021;40(4):333-7. https://www.ncbi.nlm.nih.gov/pubmed/33181782
  • Klompas M, Branson R, Eichenwald EC, Greene LR, Howell MD, Lee G, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35(8):915-36. https://www.ncbi.nlm.nih.gov/pubmed/25026607
  • Klompas M, Li L, Menchaca JT, Gruber S, Centers for Disease C, Prevention Epicenters P. Ultra-Short-Course Antibiotics for Patients With Suspected Ventilator-Associated Pneumonia but Minimal and Stable Ventilator Settings. Clin Infect Dis 2017;64(7):870-6. https://www.ncbi.nlm.nih.gov/pubmed/28034888
  • Loughlin L, Hellyer TP, White PL, McAuley DF, Conway Morris A, Posso RB, et al. Pulmonary Aspergillosis in Patients with Suspected Ventilator-associated Pneumonia in UK ICUs. Am J Respir Crit Care Med 2020;202(8):1125-32. https://www.ncbi.nlm.nih.gov/pubmed/32609533
  • Martin-Loeches I, Torres A, Rinaudo M, Terraneo S, de Rosa F, Ramirez P, et al. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. J Infect 2015;70(3):213-22. https://www.ncbi.nlm.nih.gov/pubmed/25445887
  • National Institute for Health and Care Excellence (NICE). Pneumonia in adults: diagnosis and management [CG191]. London: Public Health England; 2014. Updated July 2020. Accessed 21 Sept 2023. https://www.nice.org.uk/guidance/cg191
  • Pepper DJ, Sun J, Rhee C, Welsh J, Powers JH, 3rd, Danner RL, et al. Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults: A Systematic Review and Meta-analysis. Chest 2019;155(6):1109-18. https://www.ncbi.nlm.nih.gov/pubmed/30772386
  • Rouze A, Nseir S. Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia and Ventilator-Associated Tracheobronchitis in COVID-19. Semin Respir Crit Care Med 2022;43(2):243-7. https://www.ncbi.nlm.nih.gov/pubmed/35042264
  • Shehabi Y, Sterba M, Garrett PM, Rachakonda KS, Stephens D, Harrigan P, et al. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med 2014;190(10):1102-10. https://www.ncbi.nlm.nih.gov/pubmed/25295709
  • Smith S, Hanson J, Currie BJ. Melioidosis: An Australian Perspective. Trop Med Infect Dis 2018;3(1). https://www.ncbi.nlm.nih.gov/pubmed/30274424
  • Sogaard KK, Baettig V, Osthoff M, Marsch S, Leuzinger K, Schweitzer M, et al. Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia. J Intensive Care 2021;9(1):10. https://www.ncbi.nlm.nih.gov/pubmed/33461613
  • Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 2009;34(6):1364-75. https://www.ncbi.nlm.nih.gov/pubmed/19797133
  • Torres A, Martin-Loeches I. Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia: The Hidden Enemy? Am J Respir Crit Care Med 2020;202(8):1071-3. https://www.ncbi.nlm.nih.gov/pubmed/32730104
  • Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J 2017;50(3). https://www.ncbi.nlm.nih.gov/pubmed/28890434
  • Weiss E, Essaied W, Adrie C, Zahar JR, Timsit JF. Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials. Crit Care 2017;21(1):162. https://www.ncbi.nlm.nih.gov/pubmed/28655326
  • White PL, Dhillon R, Cordey A, Hughes H, Faggian F, Soni S, et al. A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit. Clin Infect Dis 2021;73(7):e1634-e44. https://www.ncbi.nlm.nih.gov/pubmed/32860682
  • Yoshimura J, Yamakawa K, Ohta Y, Nakamura K, Hashimoto H, Kawada M, et al. Effect of Gram Stain-Guided Initial Antibiotic Therapy on Clinical Response in Patients With Ventilator-Associated Pneumonia: The GRACE-VAP Randomized Clinical Trial. JAMA Netw Open 2022;5(4):e226136. https://www.ncbi.nlm.nih.gov/pubmed/35394515
  • Zaragoza R, Vidal-Cortes P, Aguilar G, Borges M, Diaz E, Ferrer R, et al. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care 2020;24(1):383. https://www.ncbi.nlm.nih.gov/pubmed/32600375